Neurotoxicity of soluble macrophage products in vitro-influence of dexamethasone

Experimental Neurology

Volumn 145, Issue 2 I, 1997, Pages 462-470

  Flavin, Michael P ^a   Ho, Lam T ^a   Coughlin, Kevin ^a  

^a QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINASE; DEXAMETHASONE; GLUCOCORTICOID; INDOMETACIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL MEMBRANE; CONCENTRATION RESPONSE; MACROPHAGE; MOUSE; NERVE CELL LESION; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030834296     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1997.6474     Document Type: Article

References (49)

1. Adams, D. O. 1980. Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors. J. Immunol. 124: 286-292.
2. Adams, K. O., K.-J. Kao, R. Farb, and S. V. Pizzo. 1980. Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral proteases. J. Immunol. 124: 293-300.
3. Albina, J. E., S. Cui, R. B. Mateo, and J. S. Reichner. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150: 5080-5085.
4. Barks, J. D. E., M. Post, and U. I. Tuor. 1991. Dexamethasone prevents hypoxic-ischemic brain damage in the neonatal rat. Pediatr. Res. 29: 558-563.
5. Bottenstein, J. E., and G. Sato. 1980. Growth of a rat neuroblastoma cell line in serum free supplemented medium. Proc. Natl. Acad. Sci. USA 76: 514-517.
6. Bowen, D. L., and A. S. Fauci. 1988. Adrenal corticosteroids. Pages 877-895 in J. I. Gallin, I. M. Goldstein, and R. Snyderman, Eds., Inflammation, Basic Principles and Clinical Correlates. Raven Press, New York.
7. Bracken, M. B., M. J. Shepard, and W. F. Collins. 1990. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. N. Engl. J. Med. 322: 1405-1411.
8. Brune, K., H. Kalin, K. D. Rainsford, and K. Wagner. 1980. Dexamethasone inhibits the release of prostaglandin and the formation of autophagic vacuoles from stimulated macrophages. Adv. Prostaglandin Thromboxane Res. 8: 1879-1884.
9. Cameron, D. J., and W. H. Churchill. 1981. Macrophage mediated cycototoxicity in man: Role of hydrocortisone, trypan blue, chloroquine and prednisolone. J. Neuropharmacol. 3: 77-85.
10. Cui, S., J. S. Reichner, R. B. Mateo, and J. E. Albina. 1994. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms. Cancer Res. 54: 2462-2467.
11. Drysdale, B.-E., C. M. Zacharchuk, and H. S. Shin. 1983. Mechanism of macrophage-mediated cytotoxicity: Production of a soluble cytotoxic factor. J. Immunol. 131: 2362-2367.
12. Drysdale, B.-E., S. Agarwal, and H. S. Shin. 1988. Macrophage-mediated tumoricidal activity: Mechanisms of activation and cytotoxicity. Prog. Allergy 40: 111-161.
13. Duke, R. C., and J. J. Cohen. 1992. Unit 3.17 in Current Protocols in Immunology: Morphological and Biochemical Assays of Apoptosis. Green Publishing and Wiley-Interscience, New York.
14. Farram, E., and D. S. Nelson. 1980. Mechanism of action of mouse macrophages as antitumor effector cells: Role of arginase. Cell. Immunol. 55: 283-293.
15. Fels, A. O.S., and Z. A. Cohn. 1986. The alveolar macrophage. J. Appl. Physiol. 60: 353.
16. Flavin, M. P. 1996. Influence of dexamethasone on neurotoxicity caused by oxygen and glucose deprivation in vitro. Exp. Neurol. 139: 34-38.
17. Flavin, M. P., K. Coughlin, and L. T. Ho. 1997. Soluble macrophage factors trigger apoptosis in cultured hippocampal neurons. Neuroscience, in press.
18. Flavin, M. P., Y. Yang, and R. J. Riopelle. 1992. The effect of hypoxia on neurotransmitter phenotype of forebrain cholinergic neurons. Brain Res. 583: 201-206.
19. Gehrmann, J., R. B. Banati, C. Wiessner, K.-A. Hossmann, and G. W. Kreutzberg. 1995. Reactive microglia in cerebral ischaemia: An early mediator of tissue damage? Neuropathol. Appl. Neurobiol. 21: 277-289.
20. Gehrmann, J., P. Bonnekoh, T. Miyazawa, K. A. Hossmann, and G. W. Kreutzberg. 1992. Immunocytochemical study of an early microglial activation in ischemia. J. Cereb. Blood Flow Metab. 12: 257-269.
21. Gelbard, H. A., H. J. James, L. R. Sharer, S. W. Perry, Y. Saito, A. M. Kazee, B. M. Blumberg, and L. G. Epstein. 1995. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol. Appl. Neurobiol. 21: 208-217.
22. Giulian, D., and C. Robertson. 1990. Inhibition of mononuclear phagocytes reduces ischemic injury in the spinal cord. Ann. Neurol. 27: 33-42.
23. Gross, C. E., M. M. Bednar, D. B. Howard, and M. B. Sporn. 1993. Transforming growth factor-1 reduces infarct size after experimental cerebral ischemia in a rabbit model. Stroke 24: 558-562.
24. Guyre, P. M., M. T. Girard, P. M. Morganelli, and P. D. Manganiello. 1988. Glucocorticoid effects on the production and actions of immune cytokines. J. Steroid Biochem. 30: 89-93.
25. Hamilton, J. A., G. A. Whitty, J. Wojta, M. Gallichio, K. McGrath, and G. Ianches. 1993. Regulation of plasminogen activator inhibitor-1 levels in human monocytes. Cell. Immunol. 152: 7-17.
26. Hibbs, J. B. 1974. Heterocytolysis by macrophages activated by Bacillus Calmette-Guerin: Lysosome exocytosis into tumor cells. Science 184: 468-471.
27. Inoue, K., S. Koizumi, K. Nakajima, M. Hamanoue, and S. Kohsaka. 1994. Modulatory effect of plasminogen on NMDA-induced increase in intracellular free calcium concentration in rat cultured hippocampal neurons. Neurosci. Lett. 179: 87-90.
28. Kilbourn, R. G., J. Klostergaard, and G. Lopez-Berestein. 1984. Activated macrophages secrete a soluble factor that inhibits mitochondrial respiration of tumor cells. J. Immunol. 133: 2577-2581.
29. Klempt, N. D., E. Sirimanne, A. J. Gunn, M. Klempt, K. Singh, C. Williams, and P. D. Gluckman. 1992. Hypoxia-ischemia induces transforming growth factor B mRNA in the infant rat brain. Mol. Brain Res. 13: 93-101.
30. Kochanek, P. M., and J. M. Hallenbeck. 1992. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 23: 1367-1379.
31. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
32. Lees, G. 1993. The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J. Neurol. Sci. 114: 119-122.
33. Lodge, P. A., and S. Sriram. 1996. Regulation of microglial activation by TGF-B, IL-10, and CSF-1. J. Leukocyte Biol. 60: 502-508.
34. Morioka, T., A. Kalehua, and W. J. Streit. 1991. Microglial reaction in the rat dorsal hippocampus following transient forebrain ischemia. J. Cereb. Blood Flow Metab. 11: 966-973.
35. Morrison, R. S., A. Sharma, J. De Vellis, and R. A. Bradshaw. 1986. Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc. Natl. Acad. Sci. USA 83: 7537-7541.
36. Nakamura, Y., T. Murai, and Y. Ogawa. 1996. Effect of in vitro and in vivo administration of dexamethasone on rat macrophage functions: Comparison between alveolar and peritoneal macrophages. Eur. Respir. J. 9: 301-306.
37. Nathan, C. F., H. W. Murray, and Z. A. Cohn. 1980. The macrophage as an effector cell. N. Engl. J. Med. 303: 622-626.
38. Nishi, R. 1994. Neurotrophic factors: Two are better than one. Science 265: 1052-1053.
39. Norris, J. W., and V. C. Hachinski. 1986. High dose steroid treatment in cerebral infarction. Br. Med. J. 292: 21-23.
40. Nowicki, J. P., D. Duval, H. Poignet, and B. Scatton. 1991. Nitric oxide mediates neuronal death after focal cerebral ischemia in the mouse. Eur. J. Pharmacol. 204: 339-340.
41. Page, R. C., P. Davies, and A. C. Allison. 1978. The macrophage as a secretory cell. Pages 119-157 in G. H. Bourne and J. F. Danielli, Eds., International Review of Cytology, Vol. 52. Academic Press, San Diego.
42. Rosenberg, P. A. 1991. Accumulation of extracellular glutamate and neuronal death in astrocyte-poor cortical cultures exposed to glutamine. Glia 4: 91-100.
43. Roshol, H., K. K. Skrede, C. E. Ero, and P. Wiik. 1995. Dexamethasone and methylprednisolone affect rat peritoneal phagocyte chemiluminescence after administration in vivo. Eur. J. Pharmacol. 286: 9-17.
44. Sapolsky, R. M., and W. A. Pulsinelli. 1985. Glucocorticoids potentiate ischemic injury of neurons: Therapeutic implications. Science 229: 1397-1400.
45. Schaffner, A. 1985. Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J. Clin. Invest. 76: 1755-1764.
46. Selmaj, K. W., and C. S. Raine. 1988. TNFa mediates myelin and oligodendrocyte damage in vitro. Ann. Neurol. 23: 339-346.
47. Thery, C., B. Chamak, and M. Mallat. 1991. Cytotoxic effect of brain macrophages on developing neurons. Eur. J. Neurosci. 3: 1155-1164.
48. Thery, C., B. Chamak, and M. Mallat. 1993. Neurotoxicity of brain macrophages. Clin. Neuropathol. 12: 288-290.
49. Wang, Y. F., S. F. Tsirka, S. Strickland, and S. A. Lipton. 1996. Tissue plasminogen activator knockout mice manifest smaller cerebral infarcts in a focal ischemia/reperfusion model. Soc. Neurosci. Abstr. 22: 1694.